When Bacillus subtilis was treated with a bacteriostatic concentration of clofoctol [2-(2,4dichlorobenzyl)-4-(tetramethyl-l, 1,3,3-butyl)phenol], UV-absorbing material was released. Electron micrographs showed evidence of physical alteration of the bacterial envelope. The uptake of [ 14C]glutamate was strongly inhibited by clofoctol, and preloaded glutamate was found to leak from the bacteria. Clofoctol caused an immediate and dramatic decrease in the amount of intracellular ATP. This was neither the consequence of the stimulation of an ATPase, nor of the inhibition of bacterial respiration. Both the proton gradient and the potential gradient across the cytoplasmic membrane collapsed and this inhibition of energy metabolism was sufficient to account for the inhibition of growth by clofoctol. At the same bacteriostatic concentration complete permeabilization of the bacteria occurred.
INTRODUCTION
Clofoctol is a new synthetic antibacterial agent which is active only on Gram-positive bacteria (Simonnet et al., 1979) . This compound is used in human therapy for the treatment of upper respiratory tract infections (Salet & Melekian, 1978 ; Vialatte, 1978) .
Although Gram-negative bacteria were resistant to clofoctol, spheroplasts from Escherichiu coli as well as protoplasts from Bacillus subtilis were lysed by clofoctol (F. Yablonsky, unpublished results) . Thus the resistance of Gram-negative bacteria appeared to be due to the inability of clofoctol to penetrate the outer membrane of these organisms.
The mechanism of action of clofoctol is unknown at present. It does not, however, inhibit specifically DNA, RNA or protein synthesis (Simonnet et al., 1979) . Moreover, clofoctol binds to sensitive bacteria ( lo6 to 1.5 x lo7 molecules bound per cell), but not to resistant ones (Combe et al., 1980) . The cell wall precursor UDP-N-acetylmuramyl-pentapeptide accumulated in a culture of Bacillus cereus T treated with clofoctol and the antibiotic also inhibited the incorporation of Nacetyl[ 14C]glucosamine into peptidoglycan (Yablonsky & Simonnet, 1982) . These results suggested that clofoctol might act by inhibiting synthesis of peptidoglycan. Since clofoctol is active on protoplasts and spheroplasts, we investigated the possibility that the inhibition of wall synthesis could result from the action of clofoctol on the cytoplasmic membrane. incubated with 32P04H3 (0.1 mCi ml-l; 0-5 mM) (a). After 120 rnin (arrow) clofoctol (4 yg ml-I) was added to half the culture u). Radioactivity in the cell-free extract after dilution with formic acid was determined in the ATP (a), G T P (b), and ppGpp (c) pools.
The addition of clofoctol to the culture decreased the nucleotide pools dramatically. The pools of ATP and GTP dropped by about 75 % and 56%, respectively, during the first 30 rnin ( Fig. 1 a,   b ). A consistent increase in the pool of ADP was observed (data not shown). A transient accumulation of the regulatory nucleotide, ppGpp was observed during the first 30 rnin after exposure to the drug. The levels then returned progressively to near basal values ( Fig. lc ).
ATPase activity
It seemed possible that the rapid decrease in the ATP pool caused by clofoctol might result from the inhibition of the H+-translocating ATP synthetase.
The effects of clofoctol on the ATPase of inverted vesicles were therefore compared with those of the known inhibitor, dicyclohexylcarbodiimide (DCCD) (Harold et al., 1969) . Clofoctol did not inhibit the ATPase activity, even at very high concentration (100 pg ml-l), while, as expected, DCCD (1 mM) inhibited the hydrolysis of ATP by 61%.
Oxygen uptake
The effect of clofoctol on the respiration of B. subtilis and its membrane vesicles was studied using an oxygen electrode. Figure 2 compares the respiration of bacteria treated with clofoctol(5 and 50 pg ml-I) with that of bacteria treated with potassium cyanide (1 mM). The oxygen consumption was not affected by clofoctol even at a very high concentration (50 pg ml-l), while Endogenous respiration was measured using a Hansatech electrode. Respiratory rate was measured in untreated bacteria (+) then samples were treated (arrow) with 5 pg clofoctol ml-I (0), 50 pg clofoctol ml-I (---), or 1 mM-KCN (-) and new rates were determined. Fig. 3 . Facilitation of proton uptake by clofoctol. Bacteria were suspended at 25 "C (A650 = 10) in KCl (50 mM)/MgCl, (2 mM)/glycylglycine (1 mM). Aliquots of HCl, sufficient to lower the pH to 6.2, were added at time zero, followed by addition at arrows: (a) 0.5 pg valinomycin ml-I (Val) and 2% ethanol (EtOH); (6) 0.5 pg valinomycin ml-I (Val) and 50 pg clofoctol ml-l (Clo).
it was stopped immediately with potassium cyanide. Results were similar when membrane vesicles of B. subtilis were used. The decrease in ATP concentration observed after clofoctol treatment did not therefore seem to be due to an interference of the drug with respiration.
Efects of clofoctol on the p H gradient
According to the chemiosmotic theory of Mitchell (1977) , the cytoplasmic membrane acts as an osmotic and electric barrier, driving an adenosine triphosphatase toward the synthesis of ATP by maintaining a pH gradient. We therefore examined the effects of clofoctol on the transmembrane pH gradient using two different methods.
The first method involved measuring directly the pH of a suspension of B. subtilis (Fig. 3) . In this experiment, the electrical restrictions on proton movements were relieved by valinomycin, which renders the membrane freely permeable to K+ (Harold et al., 1974; Moore & Pressman, 1964) . As clofoctol was very hydrophobic, it was diluted in ethanol and the same concentration of ethanol was used for the control. When clofoctol was added, stimulation of the translocation of protons across the membrane was demonstrated. The second method measured the effect of clofoctol on the uptake of benzoic acid [A]. This acid permeating the membrane only in its neutral form [AH] (Bakker & Mangerich, 1981) 
Addition of clofoctol and the uncoupler CCCP at the equilibrium resulted in a loss of the accumulated benzoic acid (Fig. 4) .
The internal pH calculated from equation (1) was 7.7 for the control and dropped to 7.4 when cells were treated for 10 min with clofoctol. The value of ApH (pH,,-pH,,,) varied from 0.9 for the control to 0-65 for the clofoctol-treated cells. Thus clofoctol appeared to facilitate the passage of protons across the membrane, leading to the collapse of the proton gradient. 
Eflects of clofoctol on cell permeability
Since the decrease in the ATP pool was not due to an effect of clofoctol on ATPase or on respiration, the observed collapse of the proton gradient suggests that clofoctol might alter cell permeability in general. We used the method of Harold & Baarda (1968) to investigate the possibility that the decrease in the ATP pool observed after clofoctol treatment might reflect a general effect of the drug on cell permeability, We measured the ability of B. subtilis to take up the amino acid, L-glutamic acid, in the presence of clofoctol. L-Glutamic acid was concentrated against a gradient in the cells.
The uptake of glutamic acid was strongly inhibited when the bacteria (A65o = 0.5) were treated with clofoctol (3 yg ml-l). In addition, B. subtilis preloaded with [ 14C]glutamic acid (0.1 mM, 0-025 pCi ml-l) leaked about 85% of the accumulated radioactivity during the first 5 min of incubation in fresh medium, containing clofoctol (3.3 ygml-l). In the same experiment, the effect of clofoctol on the incorporation of [14C]glutamic acid into the protein fractions was also examined. The control organisms showed a linear rate of incorporation of radioactivity, while clofoctol treatment resulted in approximately 15 % inhibition of this rate.
Similar results were obtained with preparations of membrane vesicles from B. subtilis and E. coli (results not shown). The amount of accumulated glutamate released from these preparations was about 40% during the first 5 min after addition of clofoctol.
The effect of clofoctol(4 and 6 pg ml-l) on UV leakage and on viability was measured on B. subtilis (A,,, = 0.8). UV leakage was greater at 6 pg ml-l and increased with treatment time (Fig. 5) . These concentrations of clofoctol had no effect on viability during the same period (60 min).
The appearance of the bacteria was examined by electron microscopy. An effect of the drug was observed when B. subtilis (A65o = 0.8) was treated with 6 pg ml-l clofoctol for 30 min. There was no lysis of the bacteria, but the electron micrographs revealed alterations in the bacterial envelope. Holes were seen in both the wall and the cytoplasmic membrane.
DISCUSSION
The observations reported here suggest that clofoctol alters the permeability of the envelope of B. subtilis. A consideration of the effects of clofoctol on B. subtilis suggests that this antibacterial agent affects the integrity of the cytoplasmic membrane and hence the many biochemical activities associated with it. Interaction with the membrane is suggested by the results showing leakage of cellular constituents, particularly UV-absorbing material and glutamic acid. However there was no concomitant rapid loss of viability. This suggests that, at least in the early stages, the damage to the cytoplasmic membrane caused by clofoctol may be repaired. The collapse of the intracellular pool of ATP readily accounts for the arrest of macromolecular syntheses (Simonnet et al., 1979) , including that of the cell wall (Yablonsky & Simonnet, 1982) . This reduction in ATP concentration resulted from the direct leakage of ATP across the damaged cytoplasmic membrane and by the reduction of its re-synthesis by the Mg2+,Ca2+-dependent ATPase, as shown by an increase in ADP concentration. However, a direct effect of clofoctol on the activity of the ATPase was ruled out by the experiments with inverted vesicles. A disruption of the transmembrane proton gradient remains the most probable cause.
The chemiosmotic hypothesis states that during bacterial respiration, protons are pumped out to give an electrochemical gradient across the cell membrane. This proton-motive force has electrical and chemical components such as: p = A+ -ZApH, where A+ is the membrane potential and -ApH the transmembrane pH gradient (Mitchell, 1977) . The collapse by clofoctol of both ApH and A+ resulted in additional effects similar to those of uncouplers of oxidative phosp horylation.
At present, little is known about the chemical and physical modifications of the membrane caused by clofoctol. However, electron micrographs of treated B. subtilis presented evidence of apparently non-random alteration of the whole envelope (both wall and cytoplasmic membrane). These gaps were located near the septum (or a potential septum), suggesting an interference with the biosynthetic processes of the wall,
We have already shown that clofoctol inhibits in uiuo the polymerization of UDP-Nacetylmuramyl pentapeptide leading to the accumulation of this precursor (Yablonsky & Simonnet, 1982) , but could not demonstrate in uitro inhibition of peptidoglycan synthesis. Hence, this effect is indirect and might suggest a modification of the transfer properties of the cytoplasmic membrane, which remains the most probable target of this antibacterial agent.
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